Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Golden Triangle Ventures Inc. (GTVH) New Acquisition Takes Lavish Division One Step Closer to Development of Premier Music, Art Destination

With Coachella still fresh in music lovers’ memories, it’s only natural to look at what other amazing music festivals might be looming in the future. Destino Ranch comes to mind. A new project focused on becoming an international destination where nature and technology combine to create unforgettable experiences such as outstanding music festivals, Destino Ranch […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recognizes the tremendous potential in the treatment of type 2 diabetes and obesity, and looks to address it through its patented DehydraTECH(TM) drug delivery technology that offers improved delivery of bioactive compounds. The confidence in its technology, as evidenced by the success of previous […]

SuperCom Ltd. (NASDAQ: SPCB) Preparing to Deliver on $5 Million in New Sales Orders for European Electronic Monitoring Officials

A series of new orders for electronic monitoring technology to bolster European governments’ security infrastructure is strengthening the position of SuperCom (NASDAQ: SPCB) in the EM market. The recent sales orders for SuperCom’s PureSecurity Suite of products amount to more than $5 million in revenues, orders that the growing electronic-monitoring (“EM”) security solutions provider expects […]

FinovateSpring: Revolutionizing the Future of the Fintech Industry

Attended by thousands of people worldwide, Finovate conferences are recognized as exclusive events, providing unmatched networking and growth opportunities within the fintech industry. Fintech leaders, entrepreneurs, innovators, senior bankers, investors and financial institutions are all invited to attend the Finovate Spring event being held on May 21-22, 2024, in Marriott Marquis San Francisco, San Francisco, […]

BizCann Expo 2024 by ZJ Events, is Coming to Latin America

Date: May 18-19, 2024Venue: Plaza Mayor, Medellin Colombia ZJ Events brings BizCann Expo to Latin America, hosting the BizCann Expo 2024 in Medellin, Colombia, May 18-19, 2024. This event promises to boost cannabis investments and offer phenomenal cannabis business avenues in the region. The BizCann Expo 2024 conference offers cannabis traders, entrepreneurs, legislators, enthusiasts, and […]

Btab Ecommerce Group Inc. (BBTT) Signs Letter of Intent with Integrated Wellness Acquisition Corp. (NYSE: WEL), Accelerating Company Growth

Btab Ecommerce Group (OTC: BBTT), an ecommerce company, and Integrated Wellness Acquisition Corp (NYSE: WEL), announced in February 2024 the signing of a Letter of Intent (“LOI”) for a proposed business combination. This agreement will result in Btab acquiring control of WEL, with Btab valued at an initial enterprise value of $250 million (https://ibn.fm/1Lqwi). The […]

HealthLynked Corp. (HLYK) Q4, FY2023 Financial Results; Show Bottom-line Improvements, Core Network Application Ramp-Up Expected in 2024

HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, recently announced its financial results for the fourth quarter and full year ending December 31, 2023. HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of strategic advancements and focus on healthcare technologies plus networking capabilities (https://ibn.fm/ycgvs). […]

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) Letter to Stakeholders Looks Like Launch Code to Drive Value

Zevra Therapeutics (NASDAQ: ZVRA), a rare disease therapeutics company, uniquely combines data-driven techniques, patient needs and outside the box strategies while challenging moribund drug development protocols to bring new therapeutic relief to millions of people suffering with rare diseases. With a team of expert scientists, patient advocates, development strategists, commercialization specialists, and business development gurus […]

 

From Our Blog

Why 2026 Is a Pivotal Year for Private, Pre-IPO, and Microcap Investing, and What That Means for DealFlow Discovery

January 23, 2026

As we head into January 2026, the capital markets landscape is in a period of subtle but consequential transition, one that has real implications for the direction of private company financings, pre-public valuations, and the small-cap ecosystem that DealFlow Discovery Conference now reflects. For years, microcap investing sat at the intersection of retail enthusiasm and […]

Rotate your device 90° to view site.